G72.41

HCC Category Mapping

What This Code Means

Inclusion body myositis is a rare muscle disease where the muscles gradually weaken and waste away, caused by abnormal protein deposits forming inside muscle cells. It primarily affects older adults and causes progressive weakness in the legs and arms.

Coding Tips

• •IBM is a specific form of myositis with distinct pathological findings; ensure documentation clearly distinguishes it from other myositis types (polymyositis, dermatomyositis) before coding
• •This code should be paired with appropriate manifestation codes for muscle weakness or other complications if documented, and consider adding laterality codes if the condition affects specific limbs asymmetrically

Clinical Significance

Inclusion body myositis is the most common acquired myopathy in patients over age 50, causing progressive asymmetric weakness particularly in finger flexors and quadriceps. Unlike other inflammatory myopathies, it is typically resistant to immunosuppressive therapy. Accurate coding is critical for distinguishing this treatment-resistant condition from treatable polymyositis and for reflecting the progressive disability in risk adjustment.

Documentation Requirements

• ✓Muscle biopsy showing characteristic rimmed vacuoles and endomysial inflammation with invasion of non-necrotic fibers
• ✓Clinical presentation: asymmetric weakness, finger flexion weakness, quadriceps weakness, dysphagia
• ✓Elevated or normal creatine kinase levels
• ✓Age of onset (typically >50 years)
• ✓Response to immunosuppressive therapy (typically poor in inclusion body myositis)
• ✓Provider's explicit diagnosis of inclusion body myositis, distinguished from polymyositis

Commonly Confused Codes